Merck’s $3 Billion Optimization Initiative to Fuel Next Gen Growth
Industry Insights from Next Move Strategy Consulting
As patent protection for its blockbuster cancer therapy Keytruda nears expiry in 2028, Merck on July 29 announced a comprehensive cost cutting p...
Read News
Published date :
04-Aug-2025
